BerGenBio
Solebury Trout Talks: Interview with Richard Godfrey, BerGenBio - Part of the NameTag Series
richard_qj4ya8.jpg

Itunes_kzba7m_75awwb_0.jpg

google_podcasts_badge2x_r3ddcn_c8dkjd_0.png

 

Richard Godfrey joined BerGenBio as Chief Executive Officer in 2008. He has more than 25 years' industry experience leading many international drug development and commercialisation partnerships. Formerly he served as Chief Executive Officer of Aenova Inc., a specialist biopharmaceutical company. Prior to this he was the Managing Director of DCC Healthcare Ltd and previously he held positions of increasing responsibility at Catalant, Eli Lilly and Reckitt Benckiser in RnD and commercial roles. He qualified as a Pharmacist from Liverpool University and received his M.B.A. from Bath University.